| Authors: |
Burrows GG; Center for Hematologic Malignancies, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA; Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, USA. Electronic address: ggb@ohsu.edu., Maziarz RT; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA., Hunady K; Athersys Inc., Regenerative Medicine Program, Cleveland, Ohio, USA., Lehman N; Athersys Inc., Regenerative Medicine Program, Cleveland, Ohio, USA., Raber A; Athersys Inc., Regenerative Medicine Program, Cleveland, Ohio, USA., Deans RJ; Athersys Inc., Regenerative Medicine Program, Cleveland, Ohio, USA; National Center for Regenerative Medicine, Cleveland, Ohio, USA., Van't Hof W; Athersys Inc., Regenerative Medicine Program, Cleveland, Ohio, USA; National Center for Regenerative Medicine, Cleveland, Ohio, USA. |